Hedge Fund - Acuta Capital Partners
Apellis Pharmaceuticals Inc. (APLS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $4,555,346 | 2.56% | 76,100 | $50.73 |
| 2 | 2023 - Q3 (2023-09-30) | $9,300,171 | 6.23% | 244,484 | $43.93 |
| 3 | 2023 - Q2 (2023-06-30) | $27,110,996 | 18.36% | 297,596 | $86.28 |
| 4 | 2023 - Q1 (2023-03-31) | $19,161,380 | 14.11% | 290,500 | $57.70 |
| 5 | 2022 - Q4 (2022-12-31) | $11,246,925 | 6.92% | 217,500 | $53.04 |
| 6 | 2022 - Q3 (2022-09-30) | $37,838,000 | 16.29% | 554,000 | $59.17 |
| 7 | 2022 - Q2 (2022-06-30) | $25,052,000 | 13.95% | 554,000 | $45.59 |
| 8 | 2022 - Q1 (2022-03-31) | $28,149,000 | 13.15% | 554,000 | $44.15 |
| 9 | 2021 - Q4 (2021-12-31) | $25,295,000 | 10.63% | 535,000 | $39.37 |
| 10 | 2021 - Q3 (2021-09-30) | $2,488,000 | 0.87% | 75,500 | $56.19 |
| 11 | 2021 - Q2 (2021-06-30) | $10,144,000 | 4.05% | 160,500 | $51.60 |
| 12 | 2021 - Q1 (2021-03-31) | $4,856,000 | 1.75% | 113,161 | $47.32 |
| 13 | 2020 - Q4 (2020-12-31) | $9,555,000 | 2.6% | 167,054 | $42.30 |
| 14 | 2020 - Q3 (2020-09-30) | $5,040,000 | 1.36% | 167,054 | $29.88 |
| 15 | 2020 - Q2 (2020-06-30) | $6,205,000 | 1.79% | 190,000 | $32.11 |
| 16 | 2020 - Q1 (2020-03-31) | $5,613,000 | 2.72% | 209,500 | $35.50 |
| 17 | 2019 - Q4 (2019-12-31) | $5,741,000 | 1.42% | 187,500 | $27.68 |
| 18 | 2018 - Q3 (2018-09-30) | $0 | 0% | 0 | $18.48 |
| 19 | 2018 - Q2 (2018-06-30) | $3,696,000 | 0.65% | 168,000 | $22.98 |
The displayed share prices are average quarterly stock market prices.